Recombinant Human IL-2 Protein, Active
Beta LifeScience
SKU/CAT #: BEP-0040
Recombinant Human IL-2 Protein, Active
Beta LifeScience
SKU/CAT #: BEP-0040
Regular price$31100
$311.00
/
Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human IL-2 Protein |
| Target Symbol | IL2 |
| Alternative Names | Interleukin 2, IL2, T Cell Growth Factor, TCGF, Aldesleukin, Lymphokine |
| Accession Number | P60568 |
| Expression System | E.Coli. |
| Purity | Determined by SDS-PAGE and quantitative densitometry by Coomassie® Blue staining |
| Activity | Determined by in-house activity assay |
| Formulation | Lyophilized from sterile PBS with Trehalose, pH 7.4 |
| Endotoxin Level | Available Upon Request |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | 12 months from date of receipt at -20°C to -70°C, lyophilized powder. 3 months at -20°C to -70°C under sterile conditions after reconstitution. Avoid repeated freeze-thaw cycles. |
| Reconstitution | Reconstitute at 100 ug/mL in sterile PBS. |
| Target Function | Interleukin-2 (IL-2) is a cytokine primarily produced by T cells and plays a critical role in the proliferation of T cells through paracrine and autocrine activity. It further regulates immune response through promoting the differentiation of T cells into various subsets such as effector Th17 cells or regulatory T (Treg) cells. IL-2 also promotes the differentiation and stimulation of B cell and NK cell populations. The receptor for IL-2 is a heterotrimeric complex composed of IL-2 R alpha (CD25), IL-2 R beta (CD122) and IL-2 R gamma (also named, common gamma chain or CD132). IL-2 has garnered interest in cancer immunotherapy and adoptive cell therapy (ACT) where research techniques in cell culture have included IL-2 to support the expansion and survival of modified T cells in chimeric antigen receptor (CAR) T cell therapy, tumor-infiltrating lymphocyte (TIL) therapy and NK cells. |
| Tissue Specificity | IL-2 expression has been identified in lymph node, spleen, and brain. |
| Cellular Localization | Secreted protein |
| Involvement In Disease | IL-2 dysregulation is implicated in autoimmune disorders (rheumatoid arthritis, multiple sclerosis, and type 1 diabetes), allergic asthma, allergic rhinitis, and inflammatory bowel disease (IBD). |
